2009
DOI: 10.1001/jama.2009.1415
|View full text |Cite
|
Sign up to set email alerts
|

Acid-Suppressive Medication and Hospital-Acquired Pneumonia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2010
2010
2014
2014

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 12 publications
0
1
0
Order By: Relevance
“…PPI are generally well tolerated, and with more than 100 million prescriptions each year in the US , they are among the highest‐selling drugs worldwide. Although the evidence for adverse events related to the use of PPI is limited by the absence of randomised controlled trials, there is concern that overprescribing may potentially contribute to bone fractures , pneumonia , Clostridium difficile infection , among other conditions and thus lead to escalating healthcare expenditure .…”
Section: Introductionmentioning
confidence: 99%
“…PPI are generally well tolerated, and with more than 100 million prescriptions each year in the US , they are among the highest‐selling drugs worldwide. Although the evidence for adverse events related to the use of PPI is limited by the absence of randomised controlled trials, there is concern that overprescribing may potentially contribute to bone fractures , pneumonia , Clostridium difficile infection , among other conditions and thus lead to escalating healthcare expenditure .…”
Section: Introductionmentioning
confidence: 99%